IDEX Biometrics ASA (OSL:IDEX)
Norway · Delayed Price · Currency is NOK 8.18
+0.08 (0.99%)
Aug 4, 2026, 4:25 PM CET
IDEX Biometrics ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.33 | 0.25 | 0.84 | 4.14 | 4.09 | 2.84 | |
Revenue Growth | -42.20% | -69.80% | -79.68% | 1.15% | 44.05% | 159.36% |
Cost of Revenue | 0.6 | 0.61 | 1.68 | 3.91 | 3.24 | 1.25 |
Gross Profit | -0.27 | -0.36 | -0.84 | 0.23 | 0.85 | 1.59 |
Selling, General & Admin | 2.98 | 2.65 | 8.8 | 14.31 | 19.21 | 21.11 |
Depreciation & Amortization Expenses | 0.38 | 0.48 | 2.52 | 1.64 | 1.35 | 1.8 |
Research & Development | 1.12 | 1.36 | 2.46 | 2.39 | 3.25 | 2.68 |
Other Operating Expenses | 5.21 | 5.68 | 7.29 | 8.74 | 8.4 | 7.35 |
Total Operating Expenses | 9.69 | 10.18 | 21.06 | 27.08 | 32.22 | 32.94 |
Operating Income | -7.42 | -10.53 | -21.9 | -26.85 | -31.37 | -31.35 |
Interest Income | - | 4.12 | 7.91 | 0.84 | 0.1 | 0.01 |
Interest Expense | - | -0.91 | -2.41 | -0.64 | -1.43 | -1.12 |
Other Non-Operating Income (Expense) | -0.85 | -2.72 | 1.84 | - | - | - |
Total Non-Operating Income (Expense) | -0.85 | 0.49 | 7.34 | 0.2 | -1.33 | -1.11 |
Pretax Income | -9.88 | -10.04 | -14.57 | -26.64 | -32.7 | -32.46 |
Provision for Income Taxes | -0.04 | -0.04 | -0.12 | -0.02 | 0.04 | -0.09 |
Net Income | -3.98 | -10 | -14.45 | -26.63 | -32.73 | -32.37 |
Net Income to Common | -3.98 | -10 | -14.45 | -26.63 | -32.66 | -32.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 39 | 39 | 253 | 2 | 2 |
Shares Outstanding (Diluted) | 30 | 39 | 39 | 254 | 2 | 2 |
Shares Change | 514.57% | - | -84.62% | 12210.19% | 9.74% | 21.60% |
EPS (Basic) | -0.13 | -0.26 | -0.03 | -0.11 | -16.00 | -18.00 |
EPS (Diluted) | -0.13 | -0.26 | -0.03 | -0.11 | -16.00 | -18.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.88 | -8.58 | -17.53 | -27.01 | -31.64 | -27.67 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.19 | -0.22 | -0.45 | -0.11 | -15.33 | -14.71 |
Gross Margin | -80.60% | -140.95% | -100.24% | 5.56% | 20.70% | 55.85% |
Operating Margin | -2232.98% | -4146.85% | -2604.40% | -648.79% | -766.78% | -1103.87% |
Profit Margin | -1198.04% | -3937.80% | -1718.07% | -643.50% | -800.15% | -1139.86% |
FCF Margin | -1770.85% | -3377.17% | -2084.90% | -652.61% | -773.33% | -974.44% |
EBITDA | -7.08 | -10.05 | -19.39 | -25.21 | -30.02 | -29.55 |
EBITDA Margin | -2130.31% | -3958.27% | -2305.11% | -609.28% | -733.73% | -1040.42% |
EBIT | -7.42 | -10.53 | -21.9 | -26.85 | -31.37 | -31.35 |
EBIT Margin | -2232.98% | -4146.85% | -2604.40% | -648.79% | -766.78% | -1103.87% |
Effective Tax Rate | 0.41% | 0.41% | 0.82% | 0.06% | -0.11% | 0.28% |